In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Midatech Pharma PLC

http://www.midatechpharma.com/

Latest From Midatech Pharma PLC

Midatech Survival Plan Scuppered By Shareholders

The UK firm's shareholders have not approved plans to acquire Bioasis, a decision that puts Midatech in a tricky situation as its cash will run out by mid-March.

M & A Business Strategies

Midatech Bets on Bioasis Merger For Survival

With just enough cash to stay afloat until the first quarter, Midatech is linking up with US-based, Canada-listed Bioasis to create a new rare disease player, Biodexa.

M & A Rare Diseases

New CEO of Renamed Spin-Out Fortovia Therapeutics Will Be ‘Solely US-Focused’

Newly installed Fortovia Therapeutics CEO Peter Melnyk tells Scrip his arrival and the company’s name change from Midatech Pharma US signals a strategic revamp for the privately held spin-out.

Commercial Companies

Deal Watch: Celgene Joins Line Of Partners Tapping Exscientia’s AI-Driven Discovery Engine

While the proposed Bristol/Celgene merger nears an April vote, Celgene continues a recent spate of deal-making, paying $25m up front to Exscientia to discover small molecule candidates for cancer and autoimmune disease.

Business Strategies Commercial
See All

Company Information

  • Industry
  • Biotechnology
  • Distributors
  • Pharmaceuticals
    • Specialty Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Site Specific
  • Biotechnology
    • Nanotechnology, Chips, etc.
  • Other Names / Subsidiaries
    • DARA BioSciences, Inc.
    • MidaSol Therapeutics LP
    • Midatech Group Ltd.
    • Oncogenerix, Inc.
    • Pharmida AG
    • Point Therapeutics, Inc.
UsernamePublicRestriction

Register